Background: The optimal treatment of high blood pressure (BP) after acute intra-cerebral hemorrhage (ICH) is controversial. Summary: The aim of the study was to evaluate the safety and efficacy of early intensive vs. conservative BP lowering treatment in patients with ICH. Randomized controlled trials with active and control groups receiving intensive and conservative BP lowering treatments were identified. The following outcomes were assessed: 3-month mortality and combined death or major disability, 24-h hematoma growth, early neurological deterioration, occurrence of hypotension, severe hypotension, and serious treatment-emergent adverse events. Five trials were included involving 4,350 participants, 2,162 and 2,188 for intensive and conservative treatment groups, respectively. The pooled risk ratio of 3-month death or major disability was 0.96 (0.91-1.01) and the weighted mean difference in absolute hematoma growth was -1.53 (95% CI -2.94 to -0.12) mL in the intensive compared to conservative BP-lowering. There were no differences across the treatments in the incidence rates of 3-month mortality, early neurological deterioration, hypotension, and treatment-related adverse effects other than renal events. Key Messages: The early intensive anti-hypertensive treatment was overall safe and reduced the hematoma expansion in patients presenting with acute-onset spontaneous ICH and high BP levels.

Keywords:
Blood pressure, Cerebrovascular disease, Intracerebral hemorrhage, Acute stroke
1.
Qureshi AI, Tuhrim S, Broderick JP, et al: Spontaneous intracerebral hemorrhage. N Engl J Med 2001;344:1450-1460.
2.
Qureshi AI, Ezzeddine MA, Nasar A, et al: Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med 2007;25:32-38.
3.
Moher D, Liberati A, Tetzlaff J, et al; PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097.
4.
Higgins JP, Thompson SG, Deeks JJ, et al: Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
5.
Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-1558.
6.
Deeks JJ, Higgins JPT, Altman DG: Chapter 9: analysing data and undertaking meta-analyses; in Higgins JPT, Green S (eds): Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (Updated March 2011). The Cochrane Collaboration, 2011. http://handbook.cochrane.org/ (accessed June 2016).
7.
Koch S, Romano JG, Forteza AM, et al: Rapid blood pressure reduction in acute intracerebral hemorrhage: feasibility and safety. Neurocrit Care 2008;8:316-321.
8.
Anderson CS, Huang Y, Wang JG, et al; INTERACT Investigators: Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol 2008;7:391-399.
9.
Anderson CS, Heeley E, Huang Y, et al; INTERACT2 Investigators: Rapid blood pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med 2013;368:2355-2365.
10.
Butcher KS, Jeerakathil T, Hill M, et al; ICH ADAPT Investigators: The intracerebral hemorrhage acutely decreasing arterial pressure trial. Stroke 2013;44:620-626.
11.
Qureshi AI, Palesch YY, Barsan WG, et al; ATACH-2 Trial Investigators and the Neurological Emergency Treatment Trials Network: Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med 2016;375:1033-1043.
12.
Rodriguez-Luna D, Piñeiro S, Rubiera M, et al: Impact of blood pressure changes and course on hematoma growth in acute intracerebral hemorrhage. Eur J Neurol 2013;20:1277-1283.
13.
Dandapani BK, Suzuki S, Kelley RE, et al: Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke 1995;26:21-24.
14.
Brouwers HB, Greenberg SM: Hematoma expansion following acute intracerebral hemorrhage. Cerebrovasc Dis 2013;35:195-201.
15.
Davis S, Broderick J, Hennerici M, et al; Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators: Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 2006;66:1175-1181.
16.
Anderson CS, Huang Y, Arima H, et al; INTERACT Investigators: Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT). Stroke 2010;41:307-312.
17.
Wang X, Arima H, Al-Shahi Salman R, et al: Rapid blood pressure lowering according to recovery at different time intervals after acute intracerebral hemorrhage: pooled analysis of the INTERACT studies. Cerebrovasc Dis 2015;39:242-248.
18.
Manning L, Hirakawa Y, Arima H, et al; INTERACT2 Investigators: Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial. Lancet Neurol 2014;13:364-373.
19.
Lattanzi S, Cagnetti C, Provinciali L, et al: Blood pressure variability and clinical outcome in patients with acute intracerebral hemorrhage. J Stroke Cerebrovasc Dis 2015;24:1493-1499.
20.
Lattanzi S, Silvestrini M: Optimal achieved blood pressure in acute intracerebral hemorrhage: INTERACT2. Neurology 2015;85:557-558.
21.
Lattanzi S, Silvestrini M: Blood pressure in acute intra-cerebral hemorrhage. Ann Transl Med 2016;4:320.
22.
Webb AJ, Rothwell PM: Effect of dose and combination of antihypertensives on interindividual blood pressure variability: a systematic review. Stroke 2011;42:2860-2865.
23.
Tsivgoulis G, Katsanos AH, Butcher KS, et al: Intensive blood pressure reduction in acute intracerebral hemorrhage: a meta-analysis. Neurology 2014;83:1523-1529.
24.
Ma J, Li H, Liu Y, You C, Huang S, Ma L: Effects of intensive blood pressure lowering on intracerebral hemorrhage outcomes: a meta-analysis of randomized controlled trials. Turk Neurosurg 2015;25:544-551.
25.
Pan C, Hu Y, Liu N, Zhang P, Zhang YP, Aimaiti M, Deng H, Tang YX, Xu F, Zhu SQ, Tang ZP: Aggressive blood pressure lowing therapy in patients with acute intracerebral hemorrhage is safe: a systematic review and meta-analysis. Chin Med J (Engl) 2015;128:2524-2529.
26.
Hemphill JC 3rd, Greenberg SM, Anderson CS, et al; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology: Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2015;46:2032-2060.
27.
Ankolekar S, Fuller M, Cross I, et al: Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: the rapid intervention with glyceryl trinitrate in hypertensive stroke trial (RIGHT, ISRCTN66434824). Stroke 2013;44:3120-3128.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.